Features of interaction of complexes cortisol-apolipoprotein A-I and tetrahydrocortisol-apolipoprotein A-I with eukariotic DNA

被引:0
|
作者
Panin, LE [1 ]
Tuzikov, FV
Tuzikova, NA
Polyakov, LM
机构
[1] Russian Acad Sci, Siberian Div, Inst Biochem, Novosibirsk 630117, Russia
[2] Minist Publ Hlth Russian Federat, Vector State Res Ctr Virol & Biotechnol, Koltsov 630559, Novosibirsk Reg, Russia
关键词
hepatocytes; synthesis DNA and protein; secondary structure DNA; oligonuclcleotides; cortisol; tetrahydrocortisol; apolipoprotein A-I; small-angle X-ray scattering;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
On primary culture of hepatocytes it is shown, that a complex cortisol-apolipoprotein A-I did not change rate of biosynthesis DNA and protein, whereas the complex tetrahydrocortisol-apolipoprotein A-I (THC-apoA-I) essentially raised rate of incorporation 3 H-thymidine in DNA and C-14-leucine into protein. By a method of small-angle X-ray scattering it is shown, that appreciable interaction with eukariotic DNA is marked only in case of use of a complex THC-apoA-I, thus there is local fusion of DNA. The most probable region of interaction of the given complex with DNA is repetition (GCC)(n) the type, included in structure of many genes eukariot, including the human. It is synthesized oligonucleotid (duplex) of this type. It is shown, that at his interaction with complex THC-apoA-I there is a formation of more difficult complex, which breaks up with formation of complementary chains of oligonucleotides. The last also enter interaction with complex THC-apoA-I. It is given of kinetic this multiphasic process. Interaction of a complex cortisol-anoA-I with a duplex is less specific and does not result reduce in decay of the duplex and in formation of complementary oligonucleotides.
引用
收藏
页码:300 / 309
页数:10
相关论文
共 50 条
  • [31] Apolipoprotein A-I mimetic peptides
    Brian J. Van Lenten
    Alan C. Wagner
    G. M. Anantharamaiah
    Mohamad Navab
    Srinivasa T. Reddy
    Georgette M. Buga
    Alan M. Fogelman
    Current Atherosclerosis Reports, 2009, 11 : 52 - 57
  • [32] Apolipoprotein A-I mimetic peptides
    Hovingh, G. K.
    Bochem, Andrea E.
    Kastelein, John J. P.
    CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (06) : 481 - 486
  • [33] Human Apolipoprotein A-I Mutants
    Francheschini, Guido
    HIGH DENSITY LIPOPROTEINS, DYSLIPIDEMIA, AND CORONARY HEART DISEASE, 2010, : 63 - 69
  • [34] Apolipoprotein A-I mimetic peptides
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Hama, S
    Hough, G
    Grijalva, VR
    Yu, N
    Ansell, BJ
    Datta, G
    Garber, DW
    Fogelman, AM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (07) : 1325 - 1331
  • [35] Apolipoprotein A-I induced amyloidosis
    Genschel, J
    Haas, R
    Pröpsting, MJ
    Schmidt, HHJ
    FEBS LETTERS, 1998, 430 (03): : 145 - 149
  • [36] Apolipoprotein A-I Mimetic Peptides
    Van Lenten, Brian J.
    Wagner, Alan C.
    Anantharamaiah, G. M.
    Navab, Mohamad
    Reddy, Srinivasa T.
    Buga, Georgette M.
    Fogelman, Alan M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (01) : 52 - 57
  • [37] ASPECIFICITY OF APOLIPOPROTEIN A-I ANTISERA
    COBBAERT, C
    BERTELS, I
    STAELS, B
    VERHOEVEN, G
    LISSENS, W
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (05): : 291 - 291
  • [38] IMMUNOLOGICAL ESTIMATION OF APOLIPOPROTEIN A-I
    AYRAULTJARRIER, M
    BOBILEWICZ, D
    PASTIER, D
    BEUCLER, I
    POLONOVSKI, J
    ANNALES DE BIOLOGIE CLINIQUE, 1982, 40 (03) : 187 - 194
  • [39] Human Apolipoprotein A-I Deficiency
    Schaefer, Ernst J.
    Santos, Raul D.
    HIGH DENSITY LIPOPROTEINS, DYSLIPIDEMIA, AND CORONARY HEART DISEASE, 2010, : 55 - +
  • [40] The promise of apolipoprotein A-I mimetics
    Mendez, Armando J.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2010, 17 (02) : 171 - 176